BIOFORCE NANOSCIENCES HOLDINGS, INC.
BFNHTicker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Insider trading at BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) refers to stock transactions executed by corporate insiders—officers, directors, and shareholders owning more than 10% of the company. Over the past 90 days, 2 insiders have filed 12 transactions totaling $0 in trading activity. The most active insider is Merle Ferguson (Executive), contributing $0 across 8 transactions.
BIOFORCE NANOSCIENCES HOLDINGS, INC. insiders are currently net buyers of BFNH stock, showing neutral sentiment over the past 90 days. Executives have purchased $0 while selling $0, resulting in a positive net flow of $0. This buying activity represents 50% of total transaction volume.
BIOFORCE NANOSCIENCES HOLDINGS, INC. has 2 active insiders who have filed SEC Form 4 transactions in the past 90 days. Merle Ferguson (Executive) leads with 8 transactions totaling $0. Richard Kaiser Kaiser (Executive) follows with 4 transactions worth $0. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.
The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. BIOFORCE NANOSCIENCES HOLDINGS, INC.'s current score of 50/100 indicates neutral insider sentiment. Scores between 40-60 represent neutral or mixed activity. With $0 in purchases and $0 in sales, no strong directional conviction is evident.
The most recent insider transaction occurred on Oct 18, 2023, when Ferguson Merle (Executive) disposed of 1,400,000 shares at $0.00 per share for $0. This appears to be a discretionary trade.
Based on SEC Form 4 filings from the past 90 days, BFNH insider trading sentiment is currently neutral with an Alignment Score of 50/100. The balanced activity—$0 bought vs $0 sold—suggests no strong consensus among insiders.
SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like BIOFORCE NANOSCIENCES HOLDINGS, INC.. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At BFNH, we track all Form 4 filings—currently showing 12 transactions from 2 insiders over 90 days.
A 10b5-1 plan allows BIOFORCE NANOSCIENCES HOLDINGS, INC. executives to pre-schedule stock sales when they don't possess material non-public information. At BFNH, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at BFNH appears discretionary, making insider signals more meaningful.
You can monitor BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 2 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.
Insider trading at BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of shares. These individuals must report trades to the SEC within two business days. Currently, 2 insiders are actively trading BFNH stock, having executed 12 transactions in the past 90 days. The most active insider is Merle Ferguson (Executive), with 8 transactions totaling $0.
Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. BIOFORCE NANOSCIENCES HOLDINGS, INC.'s current score of 50/100 indicates neutral sentiment with balanced buying and selling activity. This is calculated from $0 in purchases versus $0 in sales over 90 days, resulting in a net flow of $0.
SEC Form 4 filings are mandatory reports that BIOFORCE NANOSCIENCES HOLDINGS, INC. insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At BFNH, the most common type is "G" with 6 occurrences. The most recent Form 4 was filed on Oct 18, 2023 by Ferguson Merle.
Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At BIOFORCE NANOSCIENCES HOLDINGS, INC., approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at BFNH represents discretionary decisions with more informational value.
Track every insider move.
Before the market reacts.
Set alerts for BIOFORCE NANOSCIENCES HOLDINGS, INC. and 40,000+ other insiders.